Azenosertib (ZN-c3) is a selective and potent small molecule inhibitor of the Wee1 kinase. It is utilized in cancer research, particularly in studying DNA damage response and cell cycle checkpoint override, with demonstrated activity in both in vitro and in vivo preclinical models.